GVCCX | VMVAX | GVCCX / VMVAX | |
Total Expense Ratio | 2.20 | 0.07 | 3,143% |
Annual Report Gross Expense Ratio | 2.20 | 0.07 | 3,143% |
Fund Existence | 25 years | 14 years | - |
Gain YTD | 15.749 | 5.198 | 303% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 224M | 31B | 1% |
Annual Yield % from dividends | 0.00 | 2.22 | - |
Returns for 1 year | 11.82 | 7.67 | 154% |
Returns for 3 years | -8.02 | 17.51 | -46% |
Returns for 5 years | -17.82 | 65.15 | -27% |
Returns for 10 years | -49.22 | 87.87 | -56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MGICX | 37.16 | 0.20 | +0.54% |
MFS International Intrinsic Value C | |||
GCTMX | 15.39 | 0.08 | +0.52% |
Goldman Sachs International T/M Eq C | |||
LSWWX | 26.41 | -0.10 | -0.38% |
Loomis Sayles Global Allocation Y | |||
TMVIX | 24.50 | -0.12 | -0.49% |
Timothy Plan Large/Mid Cap Value I | |||
ESGIX | 17.08 | -0.09 | -0.52% |
Dana Epiphany Equity Inst |